investments JPMorgan Initiates Coverage on Divi’s Labs and Cohance Lifesciences with Overweight Ratings Arjun September 20, 2025 With strong fundamentals, capacity-led growth, and differentiated positioning, JP Morgan views both Divi’s Labs...Read More
